![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Leukemia |
Free Subscription
3 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients
and define a specific subgroup with adverse clinical features.
Am J Hematol. 2022 Apr 26. doi: 10.1002/ajh.26578.
PubMed
Abstract available
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows
acquisition of pretreatment genomic data and enrollment on investigational
clinical trials.
Am J Hematol. 2022 Apr 12. doi: 10.1002/ajh.26572.
PubMed
Abstract available
A population-based study of acute panmyelosis with myelofibrosis in the United
States: 2004-2015.
Am J Hematol. 2022;97:E144-E147.
PubMed
Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating
AIFM1.
Biochem Biophys Res Commun. 2022;606:68-74.
PubMed
Abstract available
The Paradox of Myeloid Leukemia Associated with Down Syndrome.
Biochem Pharmacol. 2022 Apr 25:115046. doi: 10.1016/j.bcp.2022.115046.
PubMed
Abstract available
Bcr-Abl drives the formation of Hsp70/Bim PPI to stabilize oncogenic clients and
prevent cells from undergoing apoptosis.
Biochem Pharmacol. 2022;198:114964.
PubMed
Abstract available
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in
T-ALL.
Blood. 2022;139:2483-2498.
PubMed
Abstract available
Firing up chromatin to forge T-ALL.
Blood. 2022;139:2418-2420.
PubMed
Characterization of metabolic alterations of Chronic Lymphocytic Leukemia in the
lymph node microenvironment.
Blood. 2022 Apr 29. pii: 485126. doi: 10.1182/blood.2021013990.
PubMed
Abstract available
Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using
machine learning.
BMC Cancer. 2022;22:433.
PubMed
Abstract available
Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related
to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia
disease, poor imatinib respondents and poor survival.
BMC Cancer. 2022;22:439.
PubMed
Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective
case-control study.
Br J Haematol. 2022;197:320-325.
PubMed
Abstract available
Very late extramedullary relapse of acute myeloid leukaemia as prostatic myeloid
sarcoma occurring 24 years post-allograft.
Br J Haematol. 2022;197:243.
PubMed
Br J Haematol. 2022;197:339-348.
PubMed
Abstract available
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic
lymphocytic leukaemia.
Br J Haematol. 2022;197:306-309.
PubMed
Abstract available
Assessing the impact of the 2017 European LeukemiaNet recommendations on FLT3
allelic ratio calculation and reporting in acute myeloid leukaemia.
Br J Haematol. 2022;197:e35-e37.
PubMed
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in
Genetically Predisposed Mice.
Cancer Res. 2022;82:1098-1109.
PubMed
Abstract available
A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte
infusion in hematologic malignancies after unmanipulated allogenic PBSCT.
Int J Hematol. 2022;115:713-727.
PubMed
Abstract available
UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
Int J Hematol. 2022;115:686-693.
PubMed
Abstract available
Uncoupling the BMP receptor antagonist function from the WNT agonist function of
R-spondin 2 using the inhibitory peptide dendrimer RW(d).
J Biol Chem. 2022;298:101586.
PubMed
Abstract available
Association Between Radioactive Iodine Treatment for Pediatric and Young
Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.
J Clin Oncol. 2022;40:1439-1449.
PubMed
Abstract available
The Influence of Body Composition on Bone Health in Long-term Survivors of Acute
Lymphoblastic Leukemia in Childhood and Adolescence: Analyses by Dual-energy
X-ray Absorptiometry and Peripheral Quantitative Computed Tomography.
J Pediatr Hematol Oncol. 2022 Apr 27. pii: 00043426-990000000-00023.
PubMed
Abstract available
Suspected Drug-induced Liver Injury Due to 6-Mercaptopurine With a Superimposed
SARS-CoV-2 Infection in a Patient With B-ALL: Erratum.
J Pediatr Hematol Oncol. 2022;44:193.
PubMed
Interaction between Avian Leukosis Virus Subgroup J Surface Protein and
Doublecortin-Like Kinase 1 Accelerates Cell Proliferation and
Epithelial-Mesenchymal Transition.
J Virol. 2022;96:e0165721.
PubMed
Abstract available
CLEC12A plays an important role in immunomodulatory function and prognostic
significance of patients with acute myeloid leukemia.
Leuk Lymphoma. 2022 Apr 23:1-13. doi: 10.1080/10428194.2022.2064986.
PubMed
Abstract available
JMJD1C-regulated lipid synthesis contributes to the maintenance of MLL-rearranged
acute myeloid leukemia.
Leuk Lymphoma. 2022 Apr 25:1-12. doi: 10.1080/10428194.2022.2068004.
PubMed
Abstract available
Average lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma,
multiple myeloma, and leukemia in Japan, 1990-2015.
Leuk Lymphoma. 2022 Apr 23:1-10. doi: 10.1080/10428194.2022.2064990.
PubMed
Abstract available
Prognostic impact of early minimal residual disease combined with complete
molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center
study.
Leuk Lymphoma. 2022 Apr 22:1-9. doi: 10.1080/10428194.2022.2064987.
PubMed
Abstract available
Tumor lysis syndrome and infectious complications during treatment with
venetoclax combined with azacitidine or decitabine in patients with acute myeloid
leukemia.
Leuk Res. 2022;117:106844.
PubMed
Abstract available
Cystine uptake inhibition potentiates front-line therapies in acute myeloid
leukemia.
Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01573.
PubMed
Abstract available
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active
CNS involvement: a retrospective international study.
Leukemia. 2022 Apr 25. pii: 10.1038/s41375-022-01546.
PubMed
Abstract available
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and
refractory acute lymphoblastic leukemia: results from a phase II trial.
Leukemia. 2022 Apr 25. pii: 10.1038/s41375-022-01576.
PubMed
Abstract available
Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid
leukemia.
Leukemia. 2022 Apr 23. pii: 10.1038/s41375-022-01579.
PubMed
Abstract available
Detection of residual and chemoresistant leukemic cells in an immune-competent
mouse model of acute myeloid leukemia: Potential for unravelling their
interactions with immunity.
PLoS One. 2022;17:e0267508.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by